Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

China cites ‘backdoor safety risk’ in Nvidia’s H20 AI chip

Yahoo Finance · 20h
Nvidia Denies 'Backdoor' Allegations in China-Bound H20 AI Chips
Washington in July cleared Nvidia to resume sales of the H20 chips to China, reversing an effective April export ban. Beijing has since sought supporting documentation on potential risks, including vulnerabilities,
Interesting Engineering on MSN · 3d
China cites ‘backdoor safety risk’ in Nvidia’s H20 AI chip; company denies allegation
China has summoned Nvidia to address alleged H20 chip security flaws, raising fresh concerns about the AI giant’s China business.
TechRepublic · 3d
China Investigates NVIDIA’s H20 Chips for Surveillance Risks
NVIDIA has been called in by Chinese regulators over claims that its H20 AI chip poses security risks, putting billions in potential sales at stake.
20h
Rising Competition In China Threatens Nvidia's Comeback
Nvidia (NASDAQ:NVDA) is set to resume sales of its H20 chips in China following a policy shift by the Trump administration.
TweakTown
23h
NVIDIA's successor to Blackwell B30 in China is its next-gen Rubin R30 AI GPU in 2028
Chinese AI companies expected to procure somewhere around 1 million of NVIDIA's next-gen Rubin R30 AI GPUs in 2028, after ...
Barchart on MSN6d
As Nvidia Gets Ready for New China H20 Shipments, How Should You Play NVDA Stock?
Nvidia (NVDA) shares remain in focus following a Reuters report that the company is warming up to resume its business in ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy